Pierpaolo Falcetta, M. Garofolo, Stefano Del Prato
{"title":"胰岛素之上的胰岛素","authors":"Pierpaolo Falcetta, M. Garofolo, Stefano Del Prato","doi":"10.30682/ildia2201f","DOIUrl":null,"url":null,"abstract":"Insulin pumps, or systems for Continuous Subcutaneous Insulin In-fusion (CSII), have changed from rudimentary devices with limited dosing flexibility to “smart” systems able to modulate insulin administration with greater flexibility and accuracy. The combination of insulin pump, continuous glucose monitoring and control algorithm now allows the automatic administration of insulin with an efficacy in glucose control never achieved previously. We review here the evolution in technology that has made possible this big advance in the care of diabetes.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Insuline oltre l’insulina\",\"authors\":\"Pierpaolo Falcetta, M. Garofolo, Stefano Del Prato\",\"doi\":\"10.30682/ildia2201f\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Insulin pumps, or systems for Continuous Subcutaneous Insulin In-fusion (CSII), have changed from rudimentary devices with limited dosing flexibility to “smart” systems able to modulate insulin administration with greater flexibility and accuracy. The combination of insulin pump, continuous glucose monitoring and control algorithm now allows the automatic administration of insulin with an efficacy in glucose control never achieved previously. We review here the evolution in technology that has made possible this big advance in the care of diabetes.\",\"PeriodicalId\":119243,\"journal\":{\"name\":\"Il Diabete\",\"volume\":\"6 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Il Diabete\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.30682/ildia2201f\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Il Diabete","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30682/ildia2201f","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Insulin pumps, or systems for Continuous Subcutaneous Insulin In-fusion (CSII), have changed from rudimentary devices with limited dosing flexibility to “smart” systems able to modulate insulin administration with greater flexibility and accuracy. The combination of insulin pump, continuous glucose monitoring and control algorithm now allows the automatic administration of insulin with an efficacy in glucose control never achieved previously. We review here the evolution in technology that has made possible this big advance in the care of diabetes.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
